T1DM
Showing 1 - 25 of >10,000
Type 1 Diabetes, Type 2 Diabetes Trial in Tunbridge Wells (Four Week Self-Compassion Course)
Not yet recruiting
- Type 1 Diabetes
- Type 2 Diabetes
- Four Week Self-Compassion Course
-
Tunbridge Wells, United KingdomSalomons Institute for Applied Psychology, Canterbury Christ Chu
Mar 1, 2023
Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)
Completed
- Endothelial Dysfunction
- +9 more
- Semaglutide Pen Injector [Ozempic]
- Empagliflozin 10 MG
-
Celje, SloveniaGeneral Hospital Celje
May 10, 2023
Brain Health and Development With T1DM
Active, not recruiting
- T1DM
- Brain Development
-
Saint Louis, MissouriWashington University School of Medicine
Feb 2, 2022
The True Vie I3 Continuous Glucose Monitoring System in
Not yet recruiting
- T1DM - Type 1 Diabetes Mellitus
- 13 CGM (continuous glucose monitor)
- (no location specified)
Jun 9, 2023
Diabetes, Diabetes, Type 1, Lipohypertrophy Trial in Roma (Medtronic Extended Infusion Set)
Completed
- Diabetes
- +2 more
- Medtronic Extended Infusion Set
-
Roma, ItalyAzienda Ospedaliera San Camillo Forlanini
Oct 6, 2023
Male LADA, T1DM and T2DM Patients
Completed
- Diabetes
- No interventions
-
Shanghai, Shanghai, ChinaDepartment of Endocrinology, Shanghai Tenth People's Hospital
Sep 8, 2022
Type 1 Diabetes Trial in Mainz, Neuss (M1 Pram P037, Insulin lispro)
Completed
- Type 1 Diabetes Mellitus
- M1 Pram P037
- Insulin lispro
-
Mainz, Germany
- +1 more
Jun 23, 2022
Diabetes, Type 1, Type 1 Diabetes Trial in Escondido (coil-reinforced soft polymer indwelling cannula, soft Teflon indwelling
Completed
- Diabetes Mellitus, Type 1
- Type 1 Diabetes
- coil-reinforced soft polymer indwelling cannula
- soft Teflon indwelling catheter
-
Escondido, CaliforniaAMCR Institute
Aug 9, 2022
Type1 Diabetes Trial in Hong Kong (Intervention arm - A new smartphone application for pediatric type 1 DM, Standard diabetic
Recruiting
- Type1 Diabetes Mellitus
- Intervention arm - A new smartphone application for pediatric type 1 DM
- Standard diabetic eduction
-
Hong Kong, Hong KongHong Kong Children's Hospital
Jun 12, 2022
Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)
Recruiting
- Type 1 Diabetes
- ECP regular-intensity arm
- +2 more
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
Oct 28, 2022
Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)
Active, not recruiting
- Diabetes Mellitus, Type 1
- AT247
- +2 more
-
Chula Vista, CaliforniaProSciento, Inc
Aug 12, 2022
Type1 Diabetes Trial in New Haven (CL/AP system, usual diabetic care)
Terminated
- Type1 Diabetes Mellitus
- CL/AP system
- usual diabetic care
-
New Haven, ConnecticutYale New Haven Hospital
Nov 16, 2022
Trastuzumab Emtansine as Therapy in Chinese HER2 Positive
Not yet recruiting
- Breast Cancer
- Trastuzumab emtansine
- (no location specified)
Jul 13, 2023
To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in
Completed
- To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
- Glargine and regular insulin versus NPH and regular insulin
-
Lahore, Punjab, PakistanPediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023
Diabetes, Type 1 Trial in Cleveland (Virtual Educational Program)
Completed
- Diabetes Mellitus, Type 1
- Virtual Educational Program
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Oct 26, 2022
Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)
Completed
- Type 1 Diabetes
- canagliflozin
- basal interruption without canagliflozin
-
New Haven, ConnecticutYale University School of Medicine
Sep 17, 2021
Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))
Recruiting
- Advanced Breast Cancer
- +2 more
- Trastuzumab Emtansine (T-DM1)
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023
Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Immunologic Deficiency Syndromes
- Sequential transplantation
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2022
Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)
Completed
- Healthy Subjects
- +2 more
- HEC88473 injection
- Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 14, 2023
Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F
Not yet recruiting
- Breast Cancer
- Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
- Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
- (no location specified)
Feb 22, 2023
Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,
Recruiting
- Salivary Gland Cancer
- HER2 Gene Mutation
- Ado-trastuzumab (T) emtansine (T-DM1)
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 2, 2023
Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)
Not yet recruiting
- Metastatic Solid Tumor
- Brain Metastases
- Trastuzumab emtansine
- Tucatinib
-
Houston, TexasM D Anderson Cancer Center
Dec 30, 2022
Type 1 Diabetes Trial in Karachi (Blood draw for insulin auto-anti body tests*)
Completed
- Type 1 Diabetes
- Blood draw for insulin auto-anti body tests*
-
Karachi, Sind, PakistanNational Institute of Child Health
Apr 21, 2022
Ado-trastuzumab Emtansine-Induced Peripheral Neuropathy in
Recruiting
- Breast Neoplasm
-
Rochester, MinnesotaMayo Clinic Minnesota
Jun 12, 2023